Teva to Acquire Allergan Generics for $40.5 Billion Creating a Transformative Generics and Specialty Company Well Positioned to Win in Global Healthcare
Go back to Teva to Acquire Allergan Generics for $40.5 Billion Creating a Transformative Generics and Specialty Company Well Positioned to Win in Global Healthcare| Allergan Inc (NYSE: AGN) | Delayed: 193.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $193.02 | 52 Week High | $322.68 | |||
| Open | $15.33 | 52 Week Low | $186.34 | |||
| Day High | $193.02 | P/E | 45.96 | |||
| Day Low | $193.02 | EPS | $4.20 | |||
| Volume | 43,377 | |||||
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 40.06 +1.08 (2.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.98 | 52 Week High | $66.55 | |||
| Open | $39.09 | 52 Week Low | $37.82 | |||
| Day High | $40.79 | P/E | N/A | |||
| Day Low | $38.36 | EPS | $0.00 | |||
| Volume | 5,941,719 | |||||
